Battery Ventures Buying Quovadx | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Battery Ventures Buying Quovadx

April 3, 2007
by root
| Reprints

Quovadx Inc., a global software company, has reached an agreement to sell its CareScience division to the Premier Inc. healthcare alliance for $34.9 million. In a second and separate transaction, Quovadx has agreed to sell the rest of the company — which includes Rogue Wave Software and Integration Solutions operating divisions — to Battery Ventures, a venture capital and private equity firm.

Quovadx's purchase price, which includes the proceeds received from the CareScience sale, is $136.7 million, subject to a working capital adjustment at closing. Thus, stated Quovadx, stockholders are expected to receive $136.7 million, or $3.15 per share, a 24 percent premium when compared to the stock's closing price on March 30.

The Health IT Summits gather 250+ healthcare leaders in cities across the U.S. to present important new insights, collaborate on ideas, and to have a little fun - Find a Summit Near You!


See more on